| Serum klotho concentration (pg/ml) | |||
---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | |
All-cause mortality | ||||
 Number of deaths (%) | 55 (26.07%) | 29 (13.88%) | 31 (14.76%) | 29 (13.74%) |
 Model 1: HR (95% CI), P value | Ref | 0.51 (0.26, 0.99) 0.049 | 0.45 (0.24, 0.81) 0.008 | 0.39 (0.22, 0.67) 0.001 |
 Model 2: HR (95% CI), P value | Ref | 0.49 (0.25, 0.97) 0.040 | 0.43 (0.23, 0.79) 0.007 | 0.43 (0.23, 0.70) 0.001 |
 Model 3: HR (95% CI), P value | Ref | 0.49 (0.25, 0.96) 0.038 | 0.44 (0.24, 0.81) 0.008 | 0.41 (0.24, 0.71) 0.001 |
Cardiovascular mortality | ||||
 Number of deaths | 18 (8.53%) | 4 (1.91%) | 6 (2.86%) | 7 (3.32%) |
 Model 1: HR (95% CI), P value | Ref | 0.21 (0.06, 0.76) 0.010 | 0.32 (0.08, 1.23) 0.100 | 0.30 (0.10, 0.88) 0.030 |
 Model 2: HR (95% CI), P value | Ref | 0.18 (0.06, 0.58) 0.004 | 0.26 (0.07, 0.93) 0.039 | 0.30 (0.12, 0.76) 0.012 |
 Model 3: HR (95% CI), P value | Ref | 0.12 (0.04, 0.38) 0.001 | 0.27 (0.08, 0.91) 0.035 | 0.24 (0.10, 0.54) 0.001 |